rs5030806

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The variant NM_000551.4(VHL):c.241C>T (p.Pro81Ser) is a missense variant in the first exon of the VHL gene. The GroupMax Filtering Allele Frequency (95% CI) in gnomAD v4.1.0 is 0.0004281 (543/1179690 from European, Non-Finnish Population). This is higher than the ClinGen VHL VCEP threshold of >=0.000156 (0.0156%) threshold expected for VHL disease (BA1). Therefore this variant meets the criterion for (BA1) and is classified as Benign for autosomal-dominant von Hippel-Lindau disease (VHL disease) based on the ACMG/AMP criteria applied, as specified by the ClinGen VHL VCEP Version 1.0 (Specifications approval date: 02/26/2024. Variant Approval Date 06/25/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA020148/MONDO:0008667/078

Frequency

Genomes: 𝑓 0.00035 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00035 ( 1 hom. )

Consequence

VHL
NM_000551.4 missense

Scores

7
8
3

Clinical Significance

Benign reviewed by expert panel P:2U:12B:15

Conservation

PhyloP100: 1.47

Publications

50 publications found
Variant links:
Genes affected
VHL (HGNC:12687): (von Hippel-Lindau tumor suppressor) This gene encodes a component of a ubiquitination complex. The encoded protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. In addition to oxygen-related gene expression, this protein plays a role in many other cellular processes including cilia formation, cytokine signaling, regulation of senescence, and formation of the extracellular matrix. Variants of this gene are associated with von Hippel-Lindau syndrome, pheochromocytoma, erythrocytosis, renal cell carcinoma, and cerebellar hemangioblastoma. [provided by RefSeq, Jun 2022]
VHL Gene-Disease associations (from GenCC):
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • von Hippel-Lindau disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Genomics England PanelApp, G2P
  • renal cell carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • autosomal recessive secondary polycythemia not associated with VHL gene
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • Chuvash polycythemia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000551.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VHL
NM_000551.4
MANE Select
c.241C>Tp.Pro81Ser
missense
Exon 1 of 3NP_000542.1A0A024R2F2
VHL
NM_001354723.2
c.241C>Tp.Pro81Ser
missense
Exon 1 of 3NP_001341652.1A0A8Q3WL21
VHL
NM_198156.3
c.241C>Tp.Pro81Ser
missense
Exon 1 of 2NP_937799.1A0A0S2Z4K1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VHL
ENST00000256474.3
TSL:1 MANE Select
c.241C>Tp.Pro81Ser
missense
Exon 1 of 3ENSP00000256474.3P40337-1
VHL
ENST00000345392.3
TSL:1
c.241C>Tp.Pro81Ser
missense
Exon 1 of 2ENSP00000344757.2P40337-2
VHL
ENST00000477538.2
TSL:1
n.287C>T
non_coding_transcript_exon
Exon 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.000348
AC:
53
AN:
152206
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000691
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000200
AC:
46
AN:
230188
AF XY:
0.000196
show subpopulations
Gnomad AFR exome
AF:
0.0000715
Gnomad AMR exome
AF:
0.0000294
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000413
Gnomad OTH exome
AF:
0.000173
GnomAD4 exome
AF:
0.000353
AC:
513
AN:
1453020
Hom.:
1
Cov.:
32
AF XY:
0.000337
AC XY:
244
AN XY:
723100
show subpopulations
African (AFR)
AF:
0.0000897
AC:
3
AN:
33458
American (AMR)
AF:
0.0000448
AC:
2
AN:
44648
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26086
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39676
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86186
European-Finnish (FIN)
AF:
0.0000442
AC:
2
AN:
45270
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.000446
AC:
496
AN:
1111658
Other (OTH)
AF:
0.000149
AC:
9
AN:
60274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
38
77
115
154
192
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000348
AC:
53
AN:
152206
Hom.:
0
Cov.:
33
AF XY:
0.000350
AC XY:
26
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.0000965
AC:
4
AN:
41466
American (AMR)
AF:
0.000131
AC:
2
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000691
AC:
47
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000597
Hom.:
0
Bravo
AF:
0.000348
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000590
AC:
5
ExAC
AF:
0.000175
AC:
21
EpiCase
AF:
0.000327
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
5
7
Von Hippel-Lindau syndrome (13)
-
2
5
not provided (7)
-
2
1
not specified (3)
-
1
1
Hereditary cancer-predisposing syndrome (2)
-
1
-
Chuvash polycythemia (1)
1
-
-
Enchondromatosis (1)
-
1
-
Hepatoblastoma (1)
-
-
1
Von Hippel-Lindau syndrome;C1837915:Chuvash polycythemia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Uncertain
0.050
T
BayesDel_noAF
Pathogenic
0.21
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.91
D
Eigen
Uncertain
0.23
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.87
D
M_CAP
Pathogenic
0.99
D
MetaRNN
Uncertain
0.55
D
MetaSVM
Pathogenic
0.99
D
MutationAssessor
Benign
1.7
L
PhyloP100
1.5
PrimateAI
Pathogenic
0.88
D
PROVEAN
Uncertain
-3.2
D
REVEL
Pathogenic
0.68
Sift
Benign
0.038
D
Sift4G
Benign
0.39
T
Polyphen
0.94
P
Vest4
0.35
MVP
1.0
MPC
0.82
ClinPred
0.33
T
GERP RS
3.2
PromoterAI
-0.042
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.81
gMVP
0.92
Mutation Taster
=7/93
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs104893829; hg19: chr3-10183772; COSMIC: COSV56546019; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.